Lite Strategy, Inc.
LITS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001262104
No open-market purchases or sales by Lite Strategy, Inc. insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $5.43M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Lite Strategy, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 29 | 29 | 0 |
| Shares | 2.43M | 2.53M | +96.0K (+4.0%) |
| Value | $16.0M | $17.7M | +$1.72M (+10.8%) |
New holders (3)
Institutions that held Lite Strategy, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Macquarie Group Ltd | 29,999 | $210.0K | 0.00% |
| Dimensional Fund Advisors LP | 10,946 | $76.7K | 0.00% |
| Qube Research & Technologies Ltd | 4 | $28 | 0.00% |
Sold out (3)
Institutions that held Lite Strategy, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Boxer Capital, LLC | 145,654 | $958.0K |
| BML Capital Management, LLC | 22,966 | $151.1K |
| Susquehanna International Group, LLP | 10,791 | $71.0K |